Home Search
epilepsy - search results
If you're not happy with the results, please do another search
Medical cannabis-based treatments: Research, production & distribution
Prof Trevor M Jones charts the priorities for research and development, production and distribution of medical cannabis-based treatments
85% of teachers in the Global South provided extra care for girls in education
Many teachers took on ‘humanitarian roles’ during COVID-19 school closures, aiming to improve girls’ education - as well as providing healthcare and safeguarding.
Alzheimer’s: A disease not just about memory loss
Head of Research Dr Sara Imarisio brings to light emerging research on the link between epilepsy and Alzheimer’s disease
Oils By Simpson™ – Cannabis Oil for better health
At OilsBySimpson we provide the highest quality of organic full-spectrum cannabis oil products, and the best customer service.
The UK health charities advancing vaccine uptake
Health charities have come into collaboration with the government and the NHS to promote and advance vaccine update, as UK hits its next milestone in the vaccine rollout.
FDA approves new non-invasive brain surgery for Parkinson’s symptoms
Research shows that a new form of non-invasive brain surgery using a focused form of ultrasound will prove invaluable for with Parkinson’s symptoms.
Can cannabidiol treat Type 2 diabetes?
Delve into the story of Kevin Simpson, who used Cannabidiol (CBD) to treat Type 2 Diabetes.
Neuromodulation clears symptoms of severe, untreatable depression
Targeted neuromodulation may be a future method to help those with severe, untreatable depression - traditionally, this is used to correct misfiring brain circuits in people with epilepsy or Parkinson's.
Neurological disorders: Developing therapies for cats, dogs & patients
Charles H. Vite, DVM, PhD from School of Veterinary Medicine at University of Pennsylvania, focuses on a fascinating aspect of neurological disorders concerning developing therapies for cats, dogs & patients.
Indiana team explores nanoparticle cure for neurological disorders
Indiana University School of Medicine researchers are attempting to use magnetic nanoparticles to develop a cure for neurological disorders from epilepsy to Alzheimer's - without any invasive or genetic treatment.
Medical devices: Technology addressing medical wellbeing
Bernard Ross, CEO of Sky Medical Technology, looks at how wearable medical technology can address some of the most critical medical issues of the 21st Century.
April 2021 North America Analysis
In the Spring edition of North America Analysis, we hear from Robert Lembo, from the National Institutes of Health, who turns the spotlight on training physician scientists and clinician investigators through the process of graduate medical education in the United States, and more.
CBD oil for ADHD: What the research shows
CBD oil is popular for its wide-ranging therapeutic benefits, but what about its effects on ADHD? Here’s what the research shows.
Open Access Government April 2021
The April 2021 edition of Open Access Government speaks about government policy issues globally, like COVID-19, health & social care, research & innovation, finance, digital transformation, agriculture, environment and energy.
Vicky Whittemore, PhD – National Institute of Neurological Disorders & Stroke, (NIH)
Dr Whittemore oversees a grant portfolio that includes basic, translational and clinical studies on epilepsy.
Vascular therapies for mental health disorders
Here, Dr Anju Vasudevan, discusses two distinct vascular therapies in the prenatal, postnatal, and adult brain to combat mental illness.
A medical professional’s opinion on medical marijuana
Dr Charlie Easmon from Your Excellent Health Service gives a medical professional’s opinion on medical marijuana in the UK, including comment on hemp, CBD and THC.
The priorities for cannabis research
Here, Robin Emerson, Head of CSR at Brains Bioceutical charts the priorities for cannabis research.
The UK’s clinicians need training in medical cannabis – here’s why
Professor Mike Barnes, Co-Founder of Maple Tree Consultancy states that the UK’s clinicians need training in medical cannabis and explains precisely why this should be.
CBD: Narcotic substance or a novel food product?
CBD is at the forefront of pharmacology. So why has the European Commission changed its recommended status to “Narcotic”? Read on to find out more.
